These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32590066)

  • 1. The impact of altered mechanobiology on aortic valve pathophysiology.
    Bardon KM; Garelnabi M
    Arch Biochem Biophys; 2020 Sep; 691():108463. PubMed ID: 32590066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory and metabolic mechanisms underlying the calcific aortic valve disease.
    Cho KI; Sakuma I; Sohn IS; Jo SH; Koh KK
    Atherosclerosis; 2018 Oct; 277():60-65. PubMed ID: 30173080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcific Aortic Valve Disease: Part 1--Molecular Pathogenetic Aspects, Hemodynamics, and Adaptive Feedbacks.
    Pasipoularides A
    J Cardiovasc Transl Res; 2016 Apr; 9(2):102-18. PubMed ID: 26891845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteogenesis in calcified aortic valve disease: From histopathological observation towards molecular understanding.
    Liu X; Xu Z
    Prog Biophys Mol Biol; 2016 Nov; 122(2):156-161. PubMed ID: 26971958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathobiology of Lp(a) in calcific aortic valve disease.
    Mathieu P; Arsenault BJ; Boulanger MC; Bossé Y; Koschinsky ML
    Expert Rev Cardiovasc Ther; 2017 Oct; 15(10):797-807. PubMed ID: 28816078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The progression of calcific aortic valve disease through injury, cell dysfunction, and disruptive biologic and physical force feedback loops.
    Li C; Xu S; Gotlieb AI
    Cardiovasc Pathol; 2013; 22(1):1-8. PubMed ID: 22795219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting vasoactive peptides for managing calcific aortic valve disease.
    Peltonen T; Ohukainen P; Ruskoaho H; Rysä J
    Ann Med; 2017 Feb; 49(1):63-74. PubMed ID: 27585243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basic mechanisms of calcific aortic valve disease.
    Mathieu P; Boulanger MC
    Can J Cardiol; 2014 Sep; 30(9):982-93. PubMed ID: 25085215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcific aortic valve disease: a consensus summary from the Alliance of Investigators on Calcific Aortic Valve Disease.
    Yutzey KE; Demer LL; Body SC; Huggins GS; Towler DA; Giachelli CM; Hofmann-Bowman MA; Mortlock DP; Rogers MB; Sadeghi MM; Aikawa E
    Arterioscler Thromb Vasc Biol; 2014 Nov; 34(11):2387-93. PubMed ID: 25189570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of calponin 2 attenuates the development of calcific aortic valve disease in ApoE
    Plazyo O; Liu R; Moazzem Hossain M; Jin JP
    J Mol Cell Cardiol; 2018 Aug; 121():233-241. PubMed ID: 30053524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of calcific aortic valve disease: Do we know enough for new clinical trials?
    Kostyunin AE; Yuzhalin AE; Ovcharenko EA; Kutikhin AG
    J Mol Cell Cardiol; 2019 Jul; 132():189-209. PubMed ID: 31136747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcific Aortic Valve Disease: a Developmental Biology Perspective.
    Dutta P; Lincoln J
    Curr Cardiol Rep; 2018 Mar; 20(4):21. PubMed ID: 29520694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated Bioinformatics Analysis Predicts the Key Genes Involved in Aortic Valve Calcification: From Hemodynamic Changes to Extracellular Remodeling.
    Liu M; Luo M; Sun H; Ni B; Shao Y
    Tohoku J Exp Med; 2017 Dec; 243(4):263-273. PubMed ID: 29212967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro 3D model and miRNA drug delivery to target calcific aortic valve disease.
    van der Ven CF; Wu PJ; Tibbitt MW; van Mil A; Sluijter JP; Langer R; Aikawa E
    Clin Sci (Lond); 2017 Feb; 131(3):181-195. PubMed ID: 28057890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local and global growth and remodeling in calcific aortic valve disease and aging.
    Sadrabadi MS; Eskandari M; Feigenbaum HP; Arzani A
    J Biomech; 2021 Nov; 128():110773. PubMed ID: 34628201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive aortic valve calcification: three-dimensional visualization and biomechanical analysis.
    Halevi R; Hamdan A; Marom G; Mega M; Raanani E; Haj-Ali R
    J Biomech; 2015 Feb; 48(3):489-97. PubMed ID: 25553668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluid-structure interaction modeling of calcific aortic valve disease using patient-specific three-dimensional calcification scans.
    Halevi R; Hamdan A; Marom G; Lavon K; Ben-Zekry S; Raanani E; Bluestein D; Haj-Ali R
    Med Biol Eng Comput; 2016 Nov; 54(11):1683-1694. PubMed ID: 26906280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innate and adaptive immunity: the understudied driving force of heart valve disease.
    Bartoli-Leonard F; Zimmer J; Aikawa E
    Cardiovasc Res; 2021 Nov; 117(13):2506-2524. PubMed ID: 34432007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shear-Sensitive Genes in Aortic Valve Endothelium.
    Fernández Esmerats J; Heath J; Jo H
    Antioxid Redox Signal; 2016 Sep; 25(7):401-14. PubMed ID: 26651130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone Morphogenetic Protein Signaling Is Required for Aortic Valve Calcification.
    Gomez-Stallons MV; Wirrig-Schwendeman EE; Hassel KR; Conway SJ; Yutzey KE
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1398-405. PubMed ID: 27199449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.